Back
Protalix BioTherapeutics Vs. Atkore Industry Stock Comparison
Buy
56
PLX
Protalix BioTherapeutics
Last Price:
1.12
Seasonality Move:
4.13%
Sell
23
ATKR
Atkore
Last Price:
152.08
Seasonality Move:
5.44%
Buy
56
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.13. The Score for PLX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Atkore (ATKR)
is a Sell
Is Atkore a Buy, Sell or Hold?
- The current Atkore [ATKR] share price is $152.15. The Score for ATKR is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ATKR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing slight selling pressure.
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.87 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.13 - 1.21) | Sell |
| Bollinger Bands (100): | (1.17 - 1.51) | Sell |
ATKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.26 | Sell |
| Relative Strength Index (14 RSI): | 38.58 | Sell |
| Chaikin Money Flow: | 524776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (150.44 - 171.92) | Sell |
| Bollinger Bands (100): | (150.14 - 177.7) | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Sell |
| 20-day SMA: | 1.16 | Sell |
| 50-day SMA: | 1.19 | Sell |
| 200-day SMA: | 1.5 | Sell |
| 8-day EMA: | 1.16 | Sell |
| 20-day EMA: | 1.17 | Sell |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 1.45 | Sell |
ATKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 153.04 | Sell |
| 20-day SMA: | 156.89 | Sell |
| 50-day SMA: | 170.46 | Sell |
| 200-day SMA: | 152.97 | Sell |
| 8-day EMA: | 153 | Sell |
| 20-day EMA: | 157.62 | Sell |
| 50-day EMA: | 163.56 | Sell |
| 200-day EMA: | 155.17 | Sell |
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Atkore Earnings Growth & ATKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.44 per share, an increase next quarter of $0.58 per share, a decrease this year of $2.72 per share, and an increase next year of $1.20 per share.
Protalix BioTherapeutics Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Atkore Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||